"","ID","Description","GeneRatio","BgRatio","pvalue","p.adjust","qvalue","geneID","Count"
"R-HSA-212436","R-HSA-212436","Generic Transcription Pathway","33/49","481/2914",1.4456863795809e-15,6.36102007015596e-13,4.45880114965478e-13,"JUN/MAPK1/MAX/MYC/SFN/SMAD3/SMAD4/TP53/WWTR1/YAP1/YWHAZ/ATR/BCL6/CDK1/CSNK2A1/CSNK2B/CTNNB1/E2F1/NOTCH1/PIN1/RB1/ATF2/FOXO4/STAT1/MEF2C/TWIST1/ARID3A/TP73/VDR/TEAD1/TEAD4/KMT2A/MYBL2",33
"R-HSA-73857","R-HSA-73857","RNA Polymerase II Transcription","33/49","499/2914",4.51647159172065e-15,9.93623750178544e-13,6.96487461249553e-13,"JUN/MAPK1/MAX/MYC/SFN/SMAD3/SMAD4/TP53/WWTR1/YAP1/YWHAZ/ATR/BCL6/CDK1/CSNK2A1/CSNK2B/CTNNB1/E2F1/NOTCH1/PIN1/RB1/ATF2/FOXO4/STAT1/MEF2C/TWIST1/ARID3A/TP73/VDR/TEAD1/TEAD4/KMT2A/MYBL2",33
"R-HSA-8878159","R-HSA-8878159","Transcriptional regulation by RUNX3","10/49","53/2914",7.86927799758258e-09,1.15416077297878e-06,8.09017001154982e-07,"MYC/SMAD3/SMAD4/TP53/WWTR1/YAP1/CTNNB1/NOTCH1/TEAD1/TEAD4",10
"R-HSA-450282","R-HSA-450282","MAPK targets/ Nuclear events mediated by MAP kinases","7/49","30/2914",3.71233684535064e-07,4.08357052988571e-05,2.8624070939151e-05,"JUN/MAPK1/MAPK9/RPS6KA2/RPS6KA5/ATF2/MEF2C",7
"R-HSA-3700989","R-HSA-3700989","Transcriptional Regulation by TP53","14/49","194/2914",1.79207548816655e-06,0.000157702642958657,0.000110542761691116,"JUN/SFN/TP53/YWHAZ/ATR/BCL6/CDK1/CSNK2A1/CSNK2B/E2F1/PIN1/ATF2/ARID3A/TP73",14
"R-HSA-9616222","R-HSA-9616222","Transcriptional regulation of granulopoiesis","6/49","27/2914",3.74283602093768e-06,0.00027447464153543,0.000192394904234165,"CEBPA/MYC/STAT3/E2F1/CEBPB/KMT2A",6
"R-HSA-8878166","R-HSA-8878166","Transcriptional regulation by RUNX2","8/49","62/2914",6.02408447371814e-06,0.000378656738347997,0.000265422067789386,"MAPK1/SMAD4/WWTR1/YAP1/CDK1/RB1/STAT1/TWIST1",8
"R-HSA-1266738","R-HSA-1266738","Developmental Biology","19/49","397/2914",8.69353774202806e-06,0.000478144575811543,0.000335158757686082,"CEBPA/JUN/MAPK1/MYC/RPS6KA2/SHC1/SMAD3/SMAD4/STAT3/CSNK2A1/CSNK2B/CTNNB1/E2F1/NOTCH1/RPS6KA5/CEBPB/MEF2C/KMT2A/MYOD1",19
"R-HSA-1538133","R-HSA-1538133","G0 and Early G1","5/49","19/2914",1.06406451231603e-05,0.000520209317132282,0.000364644329951576,"MAX/MYC/CDK1/E2F1/MYBL2",5
"R-HSA-109606","R-HSA-109606","Intrinsic Pathway for Apoptosis","7/49","49/2914",1.22918190194783e-05,0.000540840036857045,0.000379105576074436,"MAPK1/SFN/STAT3/TP53/YWHAZ/E2F1/TP73",7
"R-HSA-450341","R-HSA-450341","Activation of the AP-1 family of transcription factors","4/49","10/2914",1.37730729217812e-05,0.000550922916871246,0.000386173240773386,"JUN/MAPK1/MAPK9/ATF2",4
"R-HSA-2559583","R-HSA-2559583","Cellular Senescence","9/49","99/2914",2.78263720010306e-05,0.00102030030670446,0.000715186578622979,"JUN/MAPK1/MAPK9/RPS6KA2/STAT3/TP53/E2F1/RB1/CEBPB",9
"R-HSA-2032785","R-HSA-2032785","YAP1- and WWTR1 (TAZ)-stimulated gene expression","4/49","12/2914",3.16680563564178e-05,0.00107184190744799,0.000751315021249427,"WWTR1/YAP1/TEAD1/TEAD4",4
"R-HSA-8941326","R-HSA-8941326","RUNX2 regulates bone development","5/49","24/2914",3.65076773829301e-05,0.00114738414632066,0.000804266877684099,"MAPK1/SMAD4/WWTR1/YAP1/RB1",5
"R-HSA-157118","R-HSA-157118","Signaling by NOTCH","9/49","104/2914",4.14549202290765e-05,0.00121601099338624,0.000852371342253994,"JUN/MYC/SMAD3/TP53/YWHAZ/E2F1/NOTCH1/STAT1/IKZF1",9
"R-HSA-450294","R-HSA-450294","MAP kinase activation","7/49","60/2914",4.80187257506746e-05,0.00132051495814355,0.000925624121378135,"JUN/MAPK1/MAPK9/RPS6KA2/RPS6KA5/ATF2/MEF2C",7
"R-HSA-449147","R-HSA-449147","Signaling by Interleukins","16/49","332/2914",5.51070937023003e-05,0.00142630124876542,0.00099977575571356,"JUN/MAPK1/MAPK9/MYC/RPS6KA2/SHC1/SMAD3/STAT3/TP53/YWHAZ/BCL6/RPS6KA5/ATF2/STAT1/MEF2C/TWIST1",16
"R-HSA-448424","R-HSA-448424","Interleukin-17 signaling","7/49","64/2914",7.33887184675524e-05,0.00179394645142906,0.00125747921116917,"JUN/MAPK1/MAPK9/RPS6KA2/RPS6KA5/ATF2/MEF2C",7
"R-HSA-114452","R-HSA-114452","Activation of BH3-only proteins","5/49","29/2914",9.57438703718057e-05,0.00221722647176813,0.00155418027805757,"SFN/TP53/YWHAZ/E2F1/TP73",5
"R-HSA-6791312","R-HSA-6791312","TP53 Regulates Transcription of Cell Cycle Genes","5/49","30/2914",0.000113447474476905,0.0024958444384919,0.00174947947482806,"SFN/TP53/CDK1/E2F1/ARID3A",5
"R-HSA-9614085","R-HSA-9614085","FOXO-mediated transcription","6/49","49/2914",0.000133529905937442,0.00279776945773689,0.00196111591176294,"SFN/SMAD3/SMAD4/YWHAZ/BCL6/FOXO4",6
"R-HSA-1640170","R-HSA-1640170","Cell Cycle","13/49","249/2914",0.000151442245939448,0.00302884491878895,0.00212308985934249,"MAPK1/MAX/MYC/SFN/TP53/YWHAZ/ATR/CDK1/CSNK2A1/CSNK2B/E2F1/RB1/MYBL2",13
"R-HSA-109581","R-HSA-109581","Apoptosis","8/49","101/2914",0.000219042446290413,0.00410053520301876,0.0028742985992452,"MAPK1/SFN/STAT3/TP53/YWHAZ/CTNNB1/E2F1/TP73",8
"R-HSA-8940973","R-HSA-8940973","RUNX2 regulates osteoblast differentiation","4/49","19/2914",0.000227331592148624,0.00410053520301876,0.0028742985992452,"MAPK1/WWTR1/YAP1/RB1",4
"R-HSA-5357801","R-HSA-5357801","Programmed Cell Death","8/49","103/2914",0.000251199688345425,0.00410053520301876,0.0028742985992452,"MAPK1/SFN/STAT3/TP53/YWHAZ/CTNNB1/E2F1/TP73",8
"R-HSA-168142","R-HSA-168142","Toll Like Receptor 10 (TLR10) Cascade","7/49","78/2914",0.000260943149283012,0.00410053520301876,0.0028742985992452,"JUN/MAPK1/MAPK9/RPS6KA2/RPS6KA5/ATF2/MEF2C",7
"R-HSA-168176","R-HSA-168176","Toll Like Receptor 5 (TLR5) Cascade","7/49","78/2914",0.000260943149283012,0.00410053520301876,0.0028742985992452,"JUN/MAPK1/MAPK9/RPS6KA2/RPS6KA5/ATF2/MEF2C",7
"R-HSA-975871","R-HSA-975871","MyD88 cascade initiated on plasma membrane","7/49","78/2914",0.000260943149283012,0.00410053520301876,0.0028742985992452,"JUN/MAPK1/MAPK9/RPS6KA2/RPS6KA5/ATF2/MEF2C",7
"R-HSA-198753","R-HSA-198753","ERK/MAPK targets","4/49","21/2914",0.000342428633692955,0.00519546892499656,0.00364179998809568,"MAPK1/RPS6KA2/RPS6KA5/MEF2C",4
"R-HSA-6807070","R-HSA-6807070","PTEN Regulation","6/49","59/2914",0.000378699600115227,0.0053886085175404,0.00377718252545296,"JUN/MAPK1/TP53/CSNK2A1/CSNK2B/ATF2",6
"R-HSA-975138","R-HSA-975138","TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation","7/49","83/2914",0.00038467399581851,0.0053886085175404,0.00377718252545296,"JUN/MAPK1/MAPK9/RPS6KA2/RPS6KA5/ATF2/MEF2C",7
"R-HSA-168181","R-HSA-168181","Toll Like Receptor 7/8 (TLR7/8) Cascade","7/49","84/2914",0.000414308186936133,0.0053886085175404,0.00377718252545296,"JUN/MAPK1/MAPK9/RPS6KA2/RPS6KA5/ATF2/MEF2C",7
"R-HSA-975155","R-HSA-975155","MyD88 dependent cascade initiated on endosome","7/49","84/2914",0.000414308186936133,0.0053886085175404,0.00377718252545296,"JUN/MAPK1/MAPK9/RPS6KA2/RPS6KA5/ATF2/MEF2C",7
"R-HSA-166058","R-HSA-166058","MyD88:MAL(TIRAP) cascade initiated on plasma membrane","7/49","86/2914",0.00047907405108233,0.0053886085175404,0.00377718252545296,"JUN/MAPK1/MAPK9/RPS6KA2/RPS6KA5/ATF2/MEF2C",7
"R-HSA-168138","R-HSA-168138","Toll Like Receptor 9 (TLR9) Cascade","7/49","86/2914",0.00047907405108233,0.0053886085175404,0.00377718252545296,"JUN/MAPK1/MAPK9/RPS6KA2/RPS6KA5/ATF2/MEF2C",7
"R-HSA-168188","R-HSA-168188","Toll Like Receptor TLR6:TLR2 Cascade","7/49","86/2914",0.00047907405108233,0.0053886085175404,0.00377718252545296,"JUN/MAPK1/MAPK9/RPS6KA2/RPS6KA5/ATF2/MEF2C",7
"R-HSA-1362300","R-HSA-1362300","Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1","3/49","10/2914",0.00049375135395898,0.0053886085175404,0.00377718252545296,"CDK1/E2F1/MYBL2",3
"R-HSA-1912408","R-HSA-1912408","Pre-NOTCH Transcription and Translation","4/49","23/2914",0.000494231285899061,0.0053886085175404,0.00377718252545296,"JUN/TP53/E2F1/NOTCH1",4
"R-HSA-2559585","R-HSA-2559585","Oncogene Induced Senescence","4/49","23/2914",0.000494231285899061,0.0053886085175404,0.00377718252545296,"MAPK1/TP53/E2F1/RB1",4
"R-HSA-168164","R-HSA-168164","Toll Like Receptor 3 (TLR3) Cascade","7/49","87/2914",0.000514367176674311,0.0053886085175404,0.00377718252545296,"JUN/MAPK1/MAPK9/RPS6KA2/RPS6KA5/ATF2/MEF2C",7
"R-HSA-168179","R-HSA-168179","Toll Like Receptor TLR1:TLR2 Cascade","7/49","87/2914",0.000514367176674311,0.0053886085175404,0.00377718252545296,"JUN/MAPK1/MAPK9/RPS6KA2/RPS6KA5/ATF2/MEF2C",7
"R-HSA-181438","R-HSA-181438","Toll Like Receptor 2 (TLR2) Cascade","7/49","87/2914",0.000514367176674311,0.0053886085175404,0.00377718252545296,"JUN/MAPK1/MAPK9/RPS6KA2/RPS6KA5/ATF2/MEF2C",7
"R-HSA-198725","R-HSA-198725","Nuclear Events (kinase and transcription factor activation)","4/49","24/2914",0.000585776007602287,0.00578808869458852,0.00405720092706803,"MAPK1/RPS6KA2/RPS6KA5/MEF2C",4
"R-HSA-2173796","R-HSA-2173796","SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription","4/49","24/2914",0.000585776007602287,0.00578808869458852,0.00405720092706803,"MYC/SMAD3/SMAD4/WWTR1",4
"R-HSA-166166","R-HSA-166166","MyD88-independent TLR4 cascade ","7/49","90/2914",0.000632898348769421,0.00578808869458852,0.00405720092706803,"JUN/MAPK1/MAPK9/RPS6KA2/RPS6KA5/ATF2/MEF2C",7
"R-HSA-937061","R-HSA-937061","TRIF(TICAM1)-mediated TLR4 signaling ","7/49","90/2914",0.000632898348769421,0.00578808869458852,0.00405720092706803,"JUN/MAPK1/MAPK9/RPS6KA2/RPS6KA5/ATF2/MEF2C",7
"R-HSA-113510","R-HSA-113510","E2F mediated regulation of DNA replication","3/49","11/2914",0.000670892098690943,0.00578808869458852,0.00405720092706803,"CDK1/E2F1/RB1",3
"R-HSA-1362277","R-HSA-1362277","Transcription of E2F targets under negative control by DREAM complex","3/49","11/2914",0.000670892098690943,0.00578808869458852,0.00405720092706803,"MAX/MYC/E2F1",3
"R-HSA-6804116","R-HSA-6804116","TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest","3/49","11/2914",0.000670892098690943,0.00578808869458852,0.00405720092706803,"TP53/E2F1/ARID3A",3
"R-HSA-75035","R-HSA-75035","Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex","3/49","11/2914",0.000670892098690943,0.00578808869458852,0.00405720092706803,"SFN/YWHAZ/CDK1",3
"R-HSA-9614399","R-HSA-9614399","Regulation of localization of FOXO transcription factors","3/49","11/2914",0.000670892098690943,0.00578808869458852,0.00405720092706803,"SFN/YWHAZ/FOXO4",3
"R-HSA-2559580","R-HSA-2559580","Oxidative Stress Induced Senescence","5/49","44/2914",0.000724261432199167,0.00612836596476218,0.00429572064037158,"JUN/MAPK1/MAPK9/TP53/E2F1",5
"R-HSA-2559582","R-HSA-2559582","Senescence-Associated Secretory Phenotype (SASP)","5/49","45/2914",0.000804562863541531,0.00667938981053346,0.00468196462795767,"JUN/MAPK1/RPS6KA2/STAT3/CEBPB",5
"R-HSA-2262752","R-HSA-2262752","Cellular responses to stress","10/49","187/2914",0.000846571535459386,0.00689799028892833,0.00483519414989474,"JUN/MAPK1/MAPK9/RPS6KA2/STAT3/TP53/ATR/E2F1/RB1/CEBPB",10
"R-HSA-5633007","R-HSA-5633007","Regulation of TP53 Activity","7/49","95/2914",0.000878007863221728,0.00700343993089758,0.00490910980802151,"TP53/ATR/CDK1/CSNK2A1/CSNK2B/PIN1/TP73",7
"R-HSA-69473","R-HSA-69473","G2/M DNA damage checkpoint","5/49","46/2914",0.000891346900296055,0.00700343993089758,0.00490910980802151,"SFN/TP53/YWHAZ/ATR/CDK1",5
"R-HSA-8953897","R-HSA-8953897","Cellular responses to external stimuli","10/49","189/2914",0.000920396289476402,0.00710481346262486,0.00498016828839494,"JUN/MAPK1/MAPK9/RPS6KA2/STAT3/TP53/ATR/E2F1/RB1/CEBPB",10
"R-HSA-187037","R-HSA-187037","Signaling by NTRK1 (TRKA)","6/49","70/2914",0.000957697602101871,0.00726529215387626,0.00509265694039652,"MAPK1/RPS6KA2/SHC1/STAT3/RPS6KA5/MEF2C",6
"R-HSA-69278","R-HSA-69278","Cell Cycle, Mitotic","10/49","191/2914",0.000999474752182067,0.00745371001627304,0.0052247297482488,"MAPK1/MAX/MYC/TP53/CDK1/CSNK2A1/CSNK2B/E2F1/RB1/MYBL2",10
"R-HSA-9018519","R-HSA-9018519","Estrogen-dependent gene expression","5/49","49/2914",0.00119386218263939,0.00875498933935551,0.00613687051777791,"JUN/MYC/USF1/ATF2/FOXA1",5
"R-HSA-1912422","R-HSA-1912422","Pre-NOTCH Expression and Processing","4/49","29/2914",0.00123074160022091,0.00887748039503609,0.00622273147307554,"JUN/TP53/E2F1/NOTCH1",4
"R-HSA-2871796","R-HSA-2871796","FCERI mediated MAPK activation","4/49","30/2914",0.00140263300418153,0.00979616701333132,0.00686669123183272,"JUN/MAPK1/MAPK9/SHC1",4
"R-HSA-390466","R-HSA-390466","Chaperonin-mediated protein folding","4/49","30/2914",0.00140263300418153,0.00979616701333132,0.00686669123183272,"STAT3/TP53/CSNK2A1/CSNK2B",4
"R-HSA-9617828","R-HSA-9617828","FOXO-mediated transcription of cell cycle genes","3/49","14/2914",0.00142827661336512,0.00981940171688519,0.00688297775848651,"SMAD3/SMAD4/FOXO4",3
"R-HSA-453279","R-HSA-453279","Mitotic G1-G1/S phases","6/49","77/2914",0.00158384784871812,0.0106042891084856,0.0074331500210198,"MAX/MYC/CDK1/E2F1/RB1/MYBL2",6
"R-HSA-391251","R-HSA-391251","Protein folding","4/49","31/2914",0.00159064336627284,0.0106042891084856,0.0074331500210198,"STAT3/TP53/CSNK2A1/CSNK2B",4
"R-HSA-373760","R-HSA-373760","L1CAM interactions","5/49","53/2914",0.00170817110584846,0.0112178400981093,0.00786322284389,"MAPK1/RPS6KA2/CSNK2A1/CSNK2B/RPS6KA5",5
"R-HSA-6804114","R-HSA-6804114","TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest","3/49","15/2914",0.001764312530193,0.0114161399012488,0.00800222246666485,"SFN/TP53/CDK1",3
"R-HSA-8943724","R-HSA-8943724","Regulation of PTEN gene transcription","4/49","32/2914",0.0017955486687364,0.0114498755687539,0.00802586971685379,"JUN/MAPK1/TP53/ATF2",4
"R-HSA-8939211","R-HSA-8939211","ESR-mediated signaling","7/49","108/2914",0.00187573004750352,0.0117903031557364,0.0082644947957674,"JUN/MAPK1/MYC/SHC1/USF1/ATF2/FOXA1",7
"R-HSA-166016","R-HSA-166016","Toll Like Receptor 4 (TLR4) Cascade","7/49","110/2914",0.0020865349528245,0.0129306391442645,0.00906382121834808,"JUN/MAPK1/MAPK9/RPS6KA2/RPS6KA5/ATF2/MEF2C",7
"R-HSA-6804756","R-HSA-6804756","Regulation of TP53 Activity through Phosphorylation","5/49","56/2914",0.00218926352096339,0.0133788326281096,0.00937798555032564,"TP53/ATR/CSNK2A1/CSNK2B/PIN1",5
"R-HSA-6796648","R-HSA-6796648","TP53 Regulates Transcription of DNA Repair Genes","4/49","34/2914",0.00225912574935128,0.0136166483522543,0.00954468413208257,"JUN/TP53/ATR/ATF2",4
"R-HSA-2173793","R-HSA-2173793","Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer","4/49","36/2914",0.00279946706745288,0.0166454798605306,0.0116677645912332,"MYC/SMAD3/SMAD4/WWTR1",4
"R-HSA-69206","R-HSA-69206","G1/S Transition","5/49","60/2914",0.00297616902097324,0.0174601915897097,0.0122388424301075,"MAX/MYC/CDK1/E2F1/RB1",5
"R-HSA-9013508","R-HSA-9013508","NOTCH3 Intracellular Domain Regulates Transcription","3/49","18/2914",0.0030537352490025,0.0176795198626461,0.0123925821046777,"NOTCH1/STAT1/IKZF1",3
"R-HSA-166520","R-HSA-166520","Signaling by NTRKs","6/49","89/2914",0.00333116569743041,0.0190352325567452,0.0133428783232688,"MAPK1/RPS6KA2/SHC1/STAT3/RPS6KA5/MEF2C",6
"R-HSA-69481","R-HSA-69481","G2/M Checkpoints","5/49","62/2914",0.00343847387731087,0.0193965193079075,0.0135961247780308,"SFN/TP53/YWHAZ/ATR/CDK1",5
"R-HSA-9615017","R-HSA-9615017","FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes","3/49","19/2914",0.0035836859346626,0.0199597697626778,0.0139909390920205,"SMAD3/SMAD4/FOXO4",3
"R-HSA-170834","R-HSA-170834","Signaling by TGF-beta Receptor Complex","5/49","63/2914",0.00368811369193514,0.0202846253056433,0.0142186488386447,"MYC/SMAD3/SMAD4/WWTR1/PPP1CA",5
"R-HSA-69202","R-HSA-69202","Cyclin E associated events during G1/S transition ","4/49","39/2914",0.00376695858292638,0.0204624910677483,0.0143433250785891,"MAX/MYC/E2F1/RB1",4
"R-HSA-5663202","R-HSA-5663202","Diseases of signal transduction","11/49","268/2914",0.00395175172686386,0.0212045214612207,0.0148634564309514,"MAPK1/MYC/SHC1/SMAD3/SMAD4/STAT3/CTNNB1/NOTCH1/RAF1/FOXO4/STAT1",11
"R-HSA-69656","R-HSA-69656","Cyclin A:Cdk2-associated events at S phase entry","4/49","40/2914",0.00413422228576842,0.0215681398161847,0.0151183372395745,"MAX/MYC/E2F1/RB1",4
"R-HSA-437239","R-HSA-437239","Recycling pathway of L1","3/49","20/2914",0.00416657246449023,0.0215681398161847,0.0151183372395745,"MAPK1/RPS6KA2/RPS6KA5",3
"R-HSA-445144","R-HSA-445144","Signal transduction by L1","3/49","20/2914",0.00416657246449023,0.0215681398161847,0.0151183372395745,"MAPK1/CSNK2A1/CSNK2B",3
"R-HSA-6785807","R-HSA-6785807","Interleukin-4 and Interleukin-13 signaling","6/49","94/2914",0.00437928590266042,0.0224056488043091,0.0157053949752693,"MYC/STAT3/TP53/BCL6/STAT1/TWIST1",6
"R-HSA-168898","R-HSA-168898","Toll-like Receptor Cascades","7/49","127/2914",0.00471230274854614,0.0238323357397736,0.0167054410807504,"JUN/MAPK1/MAPK9/RPS6KA2/RPS6KA5/ATF2/MEF2C",7
"R-HSA-525793","R-HSA-525793","Myogenesis","3/49","22/2914",0.00549717628484097,0.0274858814242048,0.0192664192758182,"CTNNB1/MEF2C/MYOD1",3
"R-HSA-9006931","R-HSA-9006931","Signaling by Nuclear Receptors","7/49","136/2914",0.00685816662191139,0.033905542849899,0.0237663254904794,"JUN/MAPK1/MYC/SHC1/USF1/ATF2/FOXA1",7
"R-HSA-982772","R-HSA-982772","Growth hormone receptor signaling","3/49","24/2914",0.00705645260997939,0.0344982127598992,0.0241817615757188,"MAPK1/STAT3/STAT1",3
"R-HSA-8939236","R-HSA-8939236","RUNX1 regulates transcription of genes involved in differentiation of HSCs","3/49","27/2914",0.00984374322075716,0.0475961210673972,0.0333628312745153,"YAP1/TP73/KMT2A",3
"R-HSA-5689880","R-HSA-5689880","Ub-specific processing proteases","5/49","80/2914",0.0101844084550261,0.0487080404370814,0.0341422388709685,"MYC/SMAD3/SMAD4/TP53/FOXO4",5
"R-HSA-2173789","R-HSA-2173789","TGF-beta receptor signaling activates SMADs","3/49","28/2914",0.0108960895845432,0.0508390578097107,0.0356359902828833,"SMAD3/SMAD4/PPP1CA",3
"R-HSA-113501","R-HSA-113501","Inhibition of replication initiation of damaged DNA by RB1/E2F1","2/49","10/2914",0.0114387880071849,0.0508390578097107,0.0356359902828833,"E2F1/RB1",2
"R-HSA-6804759","R-HSA-6804759","Regulation of TP53 Activity through Association with Co-factors","2/49","10/2914",0.0114387880071849,0.0508390578097107,0.0356359902828833,"TP53/TP73",2
"R-HSA-74749","R-HSA-74749","Signal attenuation","2/49","10/2914",0.0114387880071849,0.0508390578097107,0.0356359902828833,"MAPK1/SHC1",2
"R-HSA-8934903","R-HSA-8934903","Receptor Mediated Mitophagy","2/49","10/2914",0.0114387880071849,0.0508390578097107,0.0356359902828833,"CSNK2A1/CSNK2B",2
"R-HSA-9020956","R-HSA-9020956","Interleukin-27 signaling","2/49","10/2914",0.0114387880071849,0.0508390578097107,0.0356359902828833,"STAT3/STAT1",2
"R-HSA-9020958","R-HSA-9020958","Interleukin-21 signaling","2/49","10/2914",0.0114387880071849,0.0508390578097107,0.0356359902828833,"STAT3/STAT1",2
"R-HSA-381119","R-HSA-381119","Unfolded Protein Response (UPR)","3/49","29/2914",0.0120113220442726,0.0528498169947996,0.0370454458839146,"SHC1/CEBPB/ATF4",3
"R-HSA-5633008","R-HSA-5633008","TP53 Regulates Transcription of Cell Death Genes","3/49","30/2914",0.0131900652709494,0.05635118200404,0.0394997519789085,"TP53/BCL6/TP73",3
"R-HSA-8878171","R-HSA-8878171","Transcriptional regulation by RUNX1","5/49","86/2914",0.0136829920312465,0.05635118200404,0.0394997519789085,"YAP1/CSNK2A1/CSNK2B/TP73/KMT2A",5
"R-HSA-9006936","R-HSA-9006936","Signaling by TGF-beta family members","5/49","86/2914",0.0136829920312465,0.05635118200404,0.0394997519789085,"MYC/SMAD3/SMAD4/WWTR1/PPP1CA",5
"R-HSA-1059683","R-HSA-1059683","Interleukin-6 signaling","2/49","11/2914",0.013831653764628,0.05635118200404,0.0394997519789085,"STAT3/STAT1",2
"R-HSA-380994","R-HSA-380994","ATF4 activates genes in response to endoplasmic reticulum  stress","2/49","11/2914",0.013831653764628,0.05635118200404,0.0394997519789085,"CEBPB/ATF4",2
"R-HSA-452723","R-HSA-452723","Transcriptional regulation of pluripotent stem cells","2/49","11/2914",0.013831653764628,0.05635118200404,0.0394997519789085,"SMAD4/STAT3",2
"R-HSA-6803207","R-HSA-6803207","TP53 Regulates Transcription of Caspase Activators and Caspases","2/49","11/2914",0.013831653764628,0.05635118200404,0.0394997519789085,"TP53/TP73",2
"R-HSA-8984722","R-HSA-8984722","Interleukin-35 Signalling","2/49","11/2914",0.013831653764628,0.05635118200404,0.0394997519789085,"STAT3/STAT1",2
"R-HSA-5688426","R-HSA-5688426","Deubiquitination","6/49","124/2914",0.0163936291283208,0.0645118224208062,0.045220009495924,"MYC/SMAD3/SMAD4/TP53/CDK1/FOXO4",6
"R-HSA-1483206","R-HSA-1483206","Glycerophospholipid biosynthesis","2/49","12/2914",0.0164211911616598,0.0645118224208062,0.045220009495924,"CSNK2A1/CSNK2B",2
"R-HSA-1502540","R-HSA-1502540","Signaling by Activin","2/49","12/2914",0.0164211911616598,0.0645118224208062,0.045220009495924,"SMAD3/SMAD4",2
"R-HSA-1839117","R-HSA-1839117","Signaling by cytosolic FGFR1 fusion mutants","2/49","12/2914",0.0164211911616598,0.0645118224208062,0.045220009495924,"STAT3/STAT1",2
"R-HSA-68875","R-HSA-68875","Mitotic Prophase","3/49","33/2914",0.0171123733848971,0.0666322503482719,0.0467063381627839,"MAPK1/CDK1/RB1",3
"R-HSA-5687128","R-HSA-5687128","MAPK6/MAPK4 signaling","3/49","34/2914",0.0185497844464015,0.0715956592668129,0.0501854740793689,"JUN/MYC/CDK1",3
"R-HSA-9614657","R-HSA-9614657","FOXO-mediated transcription of cell death genes","2/49","13/2914",0.0192003889319219,0.0734623576525709,0.0514939492636442,"BCL6/FOXO4",2
"R-HSA-5628897","R-HSA-5628897","TP53 Regulates Metabolic Genes","3/49","35/2914",0.0200526401347948,0.076061738442325,0.0533160032622039,"SFN/TP53/YWHAZ",3
"R-HSA-381042","R-HSA-381042","PERK regulates gene expression","2/49","14/2914",0.0221624076516814,0.0819450366952926,0.0574399419897625,"CEBPB/ATF4",2
"R-HSA-6804758","R-HSA-6804758","Regulation of TP53 Activity through Acetylation","2/49","14/2914",0.0221624076516814,0.0819450366952926,0.0574399419897625,"TP53/PIN1",2
"R-HSA-8983432","R-HSA-8983432","Interleukin-15 signaling","2/49","14/2914",0.0221624076516814,0.0819450366952926,0.0574399419897625,"SHC1/STAT3",2
"R-HSA-1257604","R-HSA-1257604","PIP3 activates AKT signaling","7/49","172/2914",0.0231356162052344,0.0845647258778613,0.0592762312971612,"JUN/MAPK1/TP53/CSNK2A1/CSNK2B/ATF2/FOXO4",7
"R-HSA-9012852","R-HSA-9012852","Signaling by NOTCH3","3/49","37/2914",0.0232552996164119,0.0845647258778613,0.0592762312971612,"NOTCH1/STAT1/IKZF1",3
"R-HSA-111447","R-HSA-111447","Activation of BAD and translocation to mitochondria ","2/49","15/2914",0.0253005761319104,0.086970730453442,0.0609627368967907,"SFN/YWHAZ",2
"R-HSA-1181150","R-HSA-1181150","Signaling by NODAL","2/49","15/2914",0.0253005761319104,0.086970730453442,0.0609627368967907,"SMAD3/SMAD4",2
"R-HSA-2028269","R-HSA-2028269","Signaling by Hippo","2/49","15/2914",0.0253005761319104,0.086970730453442,0.0609627368967907,"WWTR1/YAP1",2
"R-HSA-392517","R-HSA-392517","Rap1 signalling","2/49","15/2914",0.0253005761319104,0.086970730453442,0.0609627368967907,"YWHAZ/RAF1",2
"R-HSA-6803204","R-HSA-6803204","TP53 Regulates Transcription of Genes Involved in Cytochrome C Release","2/49","15/2914",0.0253005761319104,0.086970730453442,0.0609627368967907,"TP53/TP73",2
"R-HSA-69205","R-HSA-69205","G1/S-Specific Transcription","2/49","15/2914",0.0253005761319104,0.086970730453442,0.0609627368967907,"CDK1/E2F1",2
"R-HSA-9008059","R-HSA-9008059","Interleukin-37 signaling","2/49","15/2914",0.0253005761319104,0.086970730453442,0.0609627368967907,"SMAD3/STAT3",2
"R-HSA-453274","R-HSA-453274","Mitotic G2-G2/M phases","4/49","68/2914",0.0261293811733897,0.0891234706689261,0.0624717150861133,"TP53/CDK1/E2F1/MYBL2",4
"R-HSA-9013694","R-HSA-9013694","Signaling by NOTCH4","3/49","40/2914",0.0285522955017523,0.0946442907288896,0.0663415722094848,"SMAD3/YWHAZ/NOTCH1",3
"R-HSA-5205647","R-HSA-5205647","Mitophagy","2/49","16/2914",0.0286083878794144,0.0946442907288896,0.0663415722094848,"CSNK2A1/CSNK2B",2
"R-HSA-5668599","R-HSA-5668599","RHO GTPases Activate NADPH Oxidases","2/49","16/2914",0.0286083878794144,0.0946442907288896,0.0663415722094848,"MAPK1/PIN1",2
"R-HSA-8852276","R-HSA-8852276","The role of GTSE1 in G2/M progression after G2 checkpoint","2/49","16/2914",0.0286083878794144,0.0946442907288896,0.0663415722094848,"TP53/CDK1",2
"R-HSA-68886","R-HSA-68886","M Phase","5/49","105/2914",0.0299021412968691,0.0979548810852101,0.0686621534879583,"MAPK1/CDK1/CSNK2A1/CSNK2B/RB1",5
"R-HSA-69242","R-HSA-69242","S Phase","4/49","71/2914",0.0300543385147804,0.0979548810852101,0.0686621534879583,"MAX/MYC/E2F1/RB1",4
"R-HSA-451927","R-HSA-451927","Interleukin-2 family signaling","3/49","41/2914",0.0304491835100701,0.0985120642972855,0.0690527149260877,"SHC1/STAT3/STAT1",3
"R-HSA-9013695","R-HSA-9013695","NOTCH4 Intracellular Domain Regulates Transcription","2/49","17/2914",0.0320794976257714,0.103029043469631,0.0722189228148369,"SMAD3/NOTCH1",2
"R-HSA-201681","R-HSA-201681","TCF dependent signaling in response to WNT","5/49","108/2914",0.0332487249529031,0.106010427386068,0.074308744555306,"MYC/YWHAZ/CSNK2A1/CSNK2B/CTNNB1",5
"R-HSA-881907","R-HSA-881907","Gastrin-CREB signalling pathway via PKC and MAPK","2/49","18/2914",0.0357077179228675,0.111428339617459,0.0781064677222858,"MAPK1/RPS6KA2",2
"R-HSA-8939243","R-HSA-8939243","RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known","2/49","18/2914",0.0357077179228675,0.111428339617459,0.0781064677222858,"CSNK2A1/CSNK2B",2
"R-HSA-8953750","R-HSA-8953750","Transcriptional Regulation by E2F6","2/49","18/2914",0.0357077179228675,0.111428339617459,0.0781064677222858,"MAX/E2F1",2
"R-HSA-5621575","R-HSA-5621575","CD209 (DC-SIGN) signaling","2/49","19/2914",0.0394870158038328,0.12149851016564,0.0851652236328526,"RAF1/RPS6KA5",2
"R-HSA-6814122","R-HSA-6814122","Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding","2/49","19/2914",0.0394870158038328,0.12149851016564,0.0851652236328526,"CSNK2A1/CSNK2B",2
"R-HSA-69620","R-HSA-69620","Cell Cycle Checkpoints","5/49","114/2914",0.0406281771357702,0.124141652359298,0.0870179524910867,"SFN/TP53/YWHAZ/ATR/CDK1",5
"R-HSA-2173795","R-HSA-2173795","Downregulation of SMAD2/3:SMAD4 transcriptional activity","2/49","20/2914",0.0434115095082043,0.131731477128344,0.0923380928196287,"SMAD3/SMAD4",2
"R-HSA-168249","R-HSA-168249","Innate Immune System","12/49","428/2914",0.0465246352557959,0.140211229538015,0.0982820341020059,"JUN/MAPK1/MAPK9/RPS6KA2/SHC1/CSNK2B/CTNNB1/PIN1/RAF1/RPS6KA5/ATF2/MEF2C",12
"R-HSA-9006925","R-HSA-9006925","Intracellular signaling by second messengers","7/49","201/2914",0.0483758086717676,0.144798338881481,0.101497400220751,"JUN/MAPK1/TP53/CSNK2A1/CSNK2B/ATF2/FOXO4",7
"R-HSA-201722","R-HSA-201722","Formation of the beta-catenin:TCF transactivating complex","2/49","22/2914",0.051673294168692,0.151574996228163,0.106247545202995,"MYC/CTNNB1",2
"R-HSA-2173788","R-HSA-2173788","Downregulation of TGF-beta receptor signaling","2/49","22/2914",0.051673294168692,0.151574996228163,0.106247545202995,"SMAD3/PPP1CA",2
"R-HSA-442742","R-HSA-442742","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","2/49","22/2914",0.051673294168692,0.151574996228163,0.106247545202995,"MAPK1/RPS6KA2",2
"R-HSA-400253","R-HSA-400253","Circadian Clock","3/49","52/2914",0.0555537556089706,0.161044454751523,0.112885227852144,"PPP1CA/ATF2/MEF2C",3
"R-HSA-112409","R-HSA-112409","RAF-independent MAPK1/3 activation","2/49","23/2914",0.0559995490385977,0.161044454751523,0.112885227852144,"MAPK1/CDK1",2
"R-HSA-6783589","R-HSA-6783589","Interleukin-6 family signaling","2/49","23/2914",0.0559995490385977,0.161044454751523,0.112885227852144,"STAT3/STAT1",2
"R-HSA-2454202","R-HSA-2454202","Fc epsilon receptor (FCERI) signaling","4/49","87/2914",0.0566837398890949,0.161953542540271,0.113522459244735,"JUN/MAPK1/MAPK9/SHC1",4
"R-HSA-1643685","R-HSA-1643685","Disease","12/49","443/2914",0.0582525234236949,0.16536200197694,0.115911642534075,"JUN/MAPK1/MYC/SHC1/SMAD3/SMAD4/STAT3/CTNNB1/NOTCH1/RAF1/FOXO4/STAT1",12
"R-HSA-1839124","R-HSA-1839124","FGFR1 mutant receptor activation","2/49","24/2914",0.0604489214411994,0.167280034176904,0.117256100511562,"STAT3/STAT1",2
"R-HSA-2559586","R-HSA-2559586","DNA Damage/Telomere Stress Induced Senescence","2/49","24/2914",0.0604489214411994,0.167280034176904,0.117256100511562,"TP53/RB1",2
"R-HSA-5625740","R-HSA-5625740","RHO GTPases activate PKNs","2/49","24/2914",0.0604489214411994,0.167280034176904,0.117256100511562,"SFN/YWHAZ",2
"R-HSA-8854691","R-HSA-8854691","Interleukin-20 family signaling","2/49","24/2914",0.0604489214411994,0.167280034176904,0.117256100511562,"STAT3/STAT1",2
"R-HSA-195258","R-HSA-195258","RHO GTPase Effectors","5/49","130/2914",0.0649127495345191,0.176587314970568,0.123780103555924,"MAPK1/SFN/YWHAZ/CTNNB1/PIN1",5
"R-HSA-8864260","R-HSA-8864260","Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors","2/49","25/2914",0.065016238693709,0.176587314970568,0.123780103555924,"MYC/MYBL2",2
"R-HSA-8948751","R-HSA-8948751","Regulation of PTEN stability and activity","2/49","25/2914",0.065016238693709,0.176587314970568,0.123780103555924,"CSNK2A1/CSNK2B",2
"R-HSA-68877","R-HSA-68877","Mitotic Prometaphase","3/49","56/2914",0.0665332003524394,0.17959882303726,0.12589104102851,"CDK1/CSNK2A1/CSNK2B",3
"R-HSA-1445148","R-HSA-1445148","Translocation of SLC2A4 (GLUT4) to the plasma membrane","2/49","26/2914",0.0696964609561818,0.185857229216485,0.130277914259402,"SFN/YWHAZ",2
"R-HSA-8939902","R-HSA-8939902","Regulation of RUNX2 expression and activity","2/49","26/2914",0.0696964609561818,0.185857229216485,0.130277914259402,"STAT1/TWIST1",2
"R-HSA-5689896","R-HSA-5689896","Ovarian tumor domain proteases","2/49","27/2914",0.0744846783750157,0.197429267981969,0.138389415116548,"TP53/CDK1",2
"R-HSA-186763","R-HSA-186763","Downstream signal transduction","2/49","29/2914",0.084366092447731,0.219651364952672,0.153966148160605,"STAT3/STAT1",2
"R-HSA-6804757","R-HSA-6804757","Regulation of TP53 Degradation","2/49","29/2914",0.084366092447731,0.219651364952672,0.153966148160605,"TP53/CDK1",2
"R-HSA-6806003","R-HSA-6806003","Regulation of TP53 Expression and Degradation","2/49","29/2914",0.084366092447731,0.219651364952672,0.153966148160605,"TP53/CDK1",2
"R-HSA-1483257","R-HSA-1483257","Phospholipid metabolism","2/49","30/2914",0.0894500943889296,0.231517891359582,0.162284072173104,"CSNK2A1/CSNK2B",2
"R-HSA-3769402","R-HSA-3769402","Deactivation of the beta-catenin transactivating complex","2/49","31/2914",0.0946236967278198,0.242060619536283,0.169674070631892,"YWHAZ/CTNNB1",2
"R-HSA-5655302","R-HSA-5655302","Signaling by FGFR1 in disease","2/49","31/2914",0.0946236967278198,0.242060619536283,0.169674070631892,"STAT3/STAT1",2
"R-HSA-69275","R-HSA-69275","G2/M Transition","3/49","66/2914",0.0979029985463422,0.246900805536693,0.173066832589117,"TP53/CDK1/MYBL2",3
"R-HSA-2151201","R-HSA-2151201","Transcriptional activation of mitochondrial biogenesis","2/49","32/2914",0.0998825986034802,0.246900805536693,0.173066832589117,"ATF2/MEF2C",2
"R-HSA-3371453","R-HSA-3371453","Regulation of HSF1-mediated heat shock response","2/49","32/2914",0.0998825986034802,0.246900805536693,0.173066832589117,"MAPK1/ATR",2
"R-HSA-375165","R-HSA-375165","NCAM signaling for neurite out-growth","2/49","32/2914",0.0998825986034802,0.246900805536693,0.173066832589117,"MAPK1/RPS6KA5",2
"R-HSA-447115","R-HSA-447115","Interleukin-12 family signaling","2/49","32/2914",0.0998825986034802,0.246900805536693,0.173066832589117,"STAT3/STAT1",2
"R-HSA-6802948","R-HSA-6802948","Signaling by high-kinase activity BRAF mutants","2/49","32/2914",0.0998825986034802,0.246900805536693,0.173066832589117,"MAPK1/RAF1",2
"R-HSA-187687","R-HSA-187687","Signalling to ERKs","2/49","33/2914",0.105222613133711,0.258647764127559,0.181300944711423,"MAPK1/SHC1",2
"R-HSA-1169408","R-HSA-1169408","ISG15 antiviral mechanism","2/49","34/2914",0.110639664926668,0.267480508613923,0.187492318238946,"PIN1/STAT1",2
"R-HSA-5674135","R-HSA-5674135","MAP2K and MAPK activation","2/49","34/2914",0.110639664926668,0.267480508613923,0.187492318238946,"MAPK1/RAF1",2
"R-HSA-5675221","R-HSA-5675221","Negative regulation of MAPK pathway","2/49","34/2914",0.110639664926668,0.267480508613923,0.187492318238946,"MAPK1/RAF1",2
"R-HSA-1169410","R-HSA-1169410","Antiviral mechanism by IFN-stimulated genes","2/49","35/2914",0.116129787641327,0.279219161541989,0.195720608449289,"PIN1/STAT1",2
"R-HSA-5683057","R-HSA-5683057","MAPK family signaling cascades","6/49","202/2914",0.119870298878948,0.28664636688444,0.200926759562538,"JUN/MAPK1/MYC/SHC1/CDK1/RAF1",6
"R-HSA-9006934","R-HSA-9006934","Signaling by Receptor Tyrosine Kinases","9/49","347/2914",0.12066935587634,0.286997386949133,0.201172809512191,"MAPK1/RPS6KA2/SHC1/STAT3/YAP1/CTNNB1/RPS6KA5/STAT1/MEF2C",9
"R-HSA-5654741","R-HSA-5654741","Signaling by FGFR3","2/49","37/2914",0.127313911423296,0.301172693689518,0.211109089117293,"MAPK1/SHC1",2
"R-HSA-1592230","R-HSA-1592230","Mitochondrial biogenesis","2/49","38/2914",0.13300050377284,0.311277774787498,0.218192315819945,"ATF2/MEF2C",2
"R-HSA-5654743","R-HSA-5654743","Signaling by FGFR4","2/49","38/2914",0.13300050377284,0.311277774787498,0.218192315819945,"MAPK1/SHC1",2
"R-HSA-556833","R-HSA-556833","Metabolism of lipids","4/49","119/2914",0.137636647019138,0.320423940150373,0.22460338388531,"CSNK2A1/CSNK2B/PPP1CA/VDR",4
"R-HSA-2122947","R-HSA-2122947","NOTCH1 Intracellular Domain Regulates Transcription","2/49","40/2914",0.144544979244421,0.329532595168629,0.230988158814374,"MYC/NOTCH1",2
"R-HSA-381340","R-HSA-381340","Transcriptional regulation of white adipocyte differentiation","2/49","40/2914",0.144544979244421,0.329532595168629,0.230988158814374,"CEBPA/CEBPB",2
"R-HSA-69231","R-HSA-69231","Cyclin D associated events in G1","2/49","40/2914",0.144544979244421,0.329532595168629,0.230988158814374,"E2F1/RB1",2
"R-HSA-69236","R-HSA-69236","G1 Phase","2/49","40/2914",0.144544979244421,0.329532595168629,0.230988158814374,"E2F1/RB1",2
"R-HSA-1852241","R-HSA-1852241","Organelle biogenesis and maintenance","3/49","80/2914",0.149864708276568,0.333834572292067,0.234003659525301,"CDK1/ATF2/MEF2C",3
"R-HSA-1433557","R-HSA-1433557","Signaling by SCF-KIT","2/49","41/2914",0.150396045692337,0.333834572292067,0.234003659525301,"STAT3/STAT1",2
"R-HSA-5654736","R-HSA-5654736","Signaling by FGFR1","2/49","41/2914",0.150396045692337,0.333834572292067,0.234003659525301,"MAPK1/SHC1",2
"R-HSA-110056","R-HSA-110056","MAPK3 (ERK1) activation","1/49","10/2914",0.156207166332493,0.333834572292067,0.234003659525301,"CDK1",1
"R-HSA-111458","R-HSA-111458","Formation of apoptosome","1/49","10/2914",0.156207166332493,0.333834572292067,0.234003659525301,"MAPK1",1
"R-HSA-1221632","R-HSA-1221632","Meiotic synapsis","1/49","10/2914",0.156207166332493,0.333834572292067,0.234003659525301,"ATR",1
"R-HSA-381038","R-HSA-381038","XBP1(S) activates chaperone genes","1/49","10/2914",0.156207166332493,0.333834572292067,0.234003659525301,"SHC1",1
"R-HSA-9617629","R-HSA-9617629","Regulation of FOXO transcriptional activity by acetylation","1/49","10/2914",0.156207166332493,0.333834572292067,0.234003659525301,"FOXO4",1
"R-HSA-9627069","R-HSA-9627069","Regulation of the apoptosome activity","1/49","10/2914",0.156207166332493,0.333834572292067,0.234003659525301,"MAPK1",1
"R-HSA-6802946","R-HSA-6802946","Signaling by moderate kinase activity BRAF mutants","2/49","42/2914",0.15629527702765,0.333834572292067,0.234003659525301,"MAPK1/RAF1",2
"R-HSA-6802949","R-HSA-6802949","Signaling by RAS mutants","2/49","42/2914",0.15629527702765,0.333834572292067,0.234003659525301,"MAPK1/RAF1",2
"R-HSA-6802955","R-HSA-6802955","Paradoxical activation of RAF signaling by kinase inactive BRAF","2/49","42/2914",0.15629527702765,0.333834572292067,0.234003659525301,"MAPK1/RAF1",2
"R-HSA-9649948","R-HSA-9649948","Signaling downstream of RAS mutants","2/49","42/2914",0.15629527702765,0.333834572292067,0.234003659525301,"MAPK1/RAF1",2
"R-HSA-195721","R-HSA-195721","Signaling by WNT","5/49","172/2914",0.159776109996649,0.339620716901089,0.238059497732103,"MYC/YWHAZ/CSNK2A1/CSNK2B/CTNNB1",5
"R-HSA-1236394","R-HSA-1236394","Signaling by ERBB4","2/49","44/2914",0.168225618772838,0.355429742840203,0.24914094414397,"SHC1/YAP1",2
"R-HSA-2586552","R-HSA-2586552","Signaling by Leptin","1/49","11/2914",0.170444717589279,0.355429742840203,0.24914094414397,"STAT3",1
"R-HSA-349425","R-HSA-349425","Autodegradation of the E3 ubiquitin ligase COP1","1/49","11/2914",0.170444717589279,0.355429742840203,0.24914094414397,"TP53",1
"R-HSA-9013700","R-HSA-9013700","NOTCH4 Activation and Transmission of Signal to the Nucleus","1/49","11/2914",0.170444717589279,0.355429742840203,0.24914094414397,"YWHAZ",1
"R-HSA-1226099","R-HSA-1226099","Signaling by FGFR in disease","2/49","45/2914",0.174250642267464,0.359954378392884,0.252312518825634,"STAT3/STAT1",2
"R-HSA-512988","R-HSA-512988","Interleukin-3, Interleukin-5 and GM-CSF signaling","2/49","45/2914",0.174250642267464,0.359954378392884,0.252312518825634,"SHC1/YWHAZ",2
"R-HSA-6802952","R-HSA-6802952","Signaling by BRAF and RAF fusions","2/49","46/2914",0.180311652863353,0.360696074650611,0.252832415963228,"MAPK1/RAF1",2
"R-HSA-111461","R-HSA-111461","Cytochrome c-mediated apoptotic response","1/49","12/2914",0.184446856355426,0.360696074650611,0.252832415963228,"MAPK1",1
"R-HSA-170968","R-HSA-170968","Frs2-mediated activation","1/49","12/2914",0.184446856355426,0.360696074650611,0.252832415963228,"MAPK1",1
"R-HSA-202670","R-HSA-202670","ERKs are inactivated","1/49","12/2914",0.184446856355426,0.360696074650611,0.252832415963228,"MAPK1",1
"R-HSA-210744","R-HSA-210744","Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells","1/49","12/2914",0.184446856355426,0.360696074650611,0.252832415963228,"NOTCH1",1
"R-HSA-2691230","R-HSA-2691230","Signaling by NOTCH1 HD Domain Mutants in Cancer","1/49","12/2914",0.184446856355426,0.360696074650611,0.252832415963228,"NOTCH1",1
"R-HSA-2691232","R-HSA-2691232","Constitutive Signaling by NOTCH1 HD Domain Mutants","1/49","12/2914",0.184446856355426,0.360696074650611,0.252832415963228,"NOTCH1",1
"R-HSA-3301854","R-HSA-3301854","Nuclear Pore Complex (NPC) Disassembly","1/49","12/2914",0.184446856355426,0.360696074650611,0.252832415963228,"CDK1",1
"R-HSA-381070","R-HSA-381070","IRE1alpha activates chaperones","1/49","12/2914",0.184446856355426,0.360696074650611,0.252832415963228,"SHC1",1
"R-HSA-381771","R-HSA-381771","Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)","1/49","12/2914",0.184446856355426,0.360696074650611,0.252832415963228,"CTNNB1",1
"R-HSA-418990","R-HSA-418990","Adherens junctions interactions","1/49","12/2914",0.184446856355426,0.360696074650611,0.252832415963228,"CTNNB1",1
"R-HSA-9020558","R-HSA-9020558","Interleukin-2 signaling","1/49","12/2914",0.184446856355426,0.360696074650611,0.252832415963228,"SHC1",1
"R-HSA-438064","R-HSA-438064","Post NMDA receptor activation events","2/49","47/2914",0.186405819150243,0.362913984186314,0.254387075039689,"MAPK1/RPS6KA2",2
"R-HSA-169893","R-HSA-169893","Prolonged ERK activation events","1/49","13/2914",0.198217395307385,0.363962648956356,0.255122143885675,"MAPK1",1
"R-HSA-3906995","R-HSA-3906995","Diseases associated with O-glycosylation of proteins","1/49","13/2914",0.198217395307385,0.363962648956356,0.255122143885675,"NOTCH1",1
"R-HSA-5626467","R-HSA-5626467","RHO GTPases activate IQGAPs","1/49","13/2914",0.198217395307385,0.363962648956356,0.255122143885675,"CTNNB1",1
"R-HSA-6804760","R-HSA-6804760","Regulation of TP53 Activity through Methylation","1/49","13/2914",0.198217395307385,0.363962648956356,0.255122143885675,"TP53",1
"R-HSA-8941856","R-HSA-8941856","RUNX3 regulates NOTCH signaling","1/49","13/2914",0.198217395307385,0.363962648956356,0.255122143885675,"NOTCH1",1
"R-HSA-186797","R-HSA-186797","Signaling by PDGF","2/49","49/2914",0.198682698291604,0.363962648956356,0.255122143885675,"STAT3/STAT1",2
"R-HSA-3371556","R-HSA-3371556","Cellular response to heat stress","2/49","49/2914",0.198682698291604,0.363962648956356,0.255122143885675,"MAPK1/ATR",2
"R-HSA-442755","R-HSA-442755","Activation of NMDA receptors and postsynaptic events","2/49","49/2914",0.198682698291604,0.363962648956356,0.255122143885675,"MAPK1/RPS6KA2",2
"R-HSA-6802957","R-HSA-6802957","Oncogenic MAPK signaling","2/49","49/2914",0.198682698291604,0.363962648956356,0.255122143885675,"MAPK1/RAF1",2
"R-HSA-5654738","R-HSA-5654738","Signaling by FGFR2","2/49","50/2914",0.204860147969908,0.363962648956356,0.255122143885675,"MAPK1/SHC1",2
"R-HSA-2644602","R-HSA-2644602","Signaling by NOTCH1 PEST Domain Mutants in Cancer","2/49","51/2914",0.211060223411628,0.363962648956356,0.255122143885675,"MYC/NOTCH1",2
"R-HSA-2644603","R-HSA-2644603","Signaling by NOTCH1 in Cancer","2/49","51/2914",0.211060223411628,0.363962648956356,0.255122143885675,"MYC/NOTCH1",2
"R-HSA-2644606","R-HSA-2644606","Constitutive Signaling by NOTCH1 PEST Domain Mutants","2/49","51/2914",0.211060223411628,0.363962648956356,0.255122143885675,"MYC/NOTCH1",2
"R-HSA-2894858","R-HSA-2894858","Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer","2/49","51/2914",0.211060223411628,0.363962648956356,0.255122143885675,"MYC/NOTCH1",2
"R-HSA-2894862","R-HSA-2894862","Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants","2/49","51/2914",0.211060223411628,0.363962648956356,0.255122143885675,"MYC/NOTCH1",2
"R-HSA-1250347","R-HSA-1250347","SHC1 events in ERBB4 signaling","1/49","14/2914",0.211760086665516,0.363962648956356,0.255122143885675,"SHC1",1
"R-HSA-1295596","R-HSA-1295596","Spry regulation of FGF signaling","1/49","14/2914",0.211760086665516,0.363962648956356,0.255122143885675,"MAPK1",1
"R-HSA-180336","R-HSA-180336","SHC1 events in EGFR signaling","1/49","14/2914",0.211760086665516,0.363962648956356,0.255122143885675,"SHC1",1
"R-HSA-400508","R-HSA-400508","Incretin synthesis, secretion, and inactivation","1/49","14/2914",0.211760086665516,0.363962648956356,0.255122143885675,"CTNNB1",1
"R-HSA-4839743","R-HSA-4839743","phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex","1/49","14/2914",0.211760086665516,0.363962648956356,0.255122143885675,"CTNNB1",1
"R-HSA-5339716","R-HSA-5339716","Misspliced GSK3beta mutants stabilize beta-catenin","1/49","14/2914",0.211760086665516,0.363962648956356,0.255122143885675,"CTNNB1",1
"R-HSA-5358747","R-HSA-5358747","S33 mutants of beta-catenin aren't phosphorylated","1/49","14/2914",0.211760086665516,0.363962648956356,0.255122143885675,"CTNNB1",1
"R-HSA-5358749","R-HSA-5358749","S37 mutants of beta-catenin aren't phosphorylated","1/49","14/2914",0.211760086665516,0.363962648956356,0.255122143885675,"CTNNB1",1
"R-HSA-5358751","R-HSA-5358751","S45 mutants of beta-catenin aren't phosphorylated","1/49","14/2914",0.211760086665516,0.363962648956356,0.255122143885675,"CTNNB1",1
"R-HSA-5358752","R-HSA-5358752","T41 mutants of beta-catenin aren't phosphorylated","1/49","14/2914",0.211760086665516,0.363962648956356,0.255122143885675,"CTNNB1",1
"R-HSA-5637810","R-HSA-5637810","Constitutive Signaling by EGFRvIII","1/49","14/2914",0.211760086665516,0.363962648956356,0.255122143885675,"SHC1",1
"R-HSA-5637812","R-HSA-5637812","Signaling by EGFRvIII in Cancer","1/49","14/2914",0.211760086665516,0.363962648956356,0.255122143885675,"SHC1",1
"R-HSA-68867","R-HSA-68867","Assembly of the pre-replicative complex","1/49","14/2914",0.211760086665516,0.363962648956356,0.255122143885675,"E2F1",1
"R-HSA-877312","R-HSA-877312","Regulation of IFNG signaling","1/49","14/2914",0.211760086665516,0.363962648956356,0.255122143885675,"STAT1",1
"R-HSA-9027284","R-HSA-9027284","Erythropoietin activates RAS","1/49","14/2914",0.211760086665516,0.363962648956356,0.255122143885675,"SHC1",1
"R-HSA-74751","R-HSA-74751","Insulin receptor signalling cascade","2/49","52/2914",0.217280482123734,0.370555860986214,0.259743701600384,"MAPK1/SHC1",2
"R-HSA-74752","R-HSA-74752","Signaling by Insulin receptor","2/49","52/2914",0.217280482123734,0.370555860986214,0.259743701600384,"MAPK1/SHC1",2
"R-HSA-1632852","R-HSA-1632852","Macroautophagy","2/49","53/2914",0.223518554158087,0.372310504429207,0.260973631095114,"CSNK2A1/CSNK2B",2
"R-HSA-176412","R-HSA-176412","Phosphorylation of the APC/C","1/49","15/2914",0.225078623132203,0.372310504429207,0.260973631095114,"CDK1",1
"R-HSA-2730905","R-HSA-2730905","Role of LAT2/NTAL/LAB on calcium mobilization","1/49","15/2914",0.225078623132203,0.372310504429207,0.260973631095114,"SHC1",1
"R-HSA-69541","R-HSA-69541","Stabilization of p53","1/49","15/2914",0.225078623132203,0.372310504429207,0.260973631095114,"TP53",1
"R-HSA-8862803","R-HSA-8862803","Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models","1/49","15/2914",0.225078623132203,0.372310504429207,0.260973631095114,"JUN",1
"R-HSA-8863678","R-HSA-8863678","Neurodegenerative Diseases","1/49","15/2914",0.225078623132203,0.372310504429207,0.260973631095114,"JUN",1
"R-HSA-8876384","R-HSA-8876384","Listeria monocytogenes entry into host cells","1/49","15/2914",0.225078623132203,0.372310504429207,0.260973631095114,"CTNNB1",1
"R-HSA-9604323","R-HSA-9604323","Negative regulation of NOTCH4 signaling","1/49","15/2914",0.225078623132203,0.372310504429207,0.260973631095114,"YWHAZ",1
"R-HSA-190236","R-HSA-190236","Signaling by FGFR","2/49","55/2914",0.236039011171394,0.382473434594589,0.268097407502906,"MAPK1/SHC1",2
"R-HSA-111471","R-HSA-111471","Apoptotic factor-mediated response","1/49","16/2914",0.238176638815721,0.382473434594589,0.268097407502906,"MAPK1",1
"R-HSA-1236382","R-HSA-1236382","Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants","1/49","16/2914",0.238176638815721,0.382473434594589,0.268097407502906,"SHC1",1
"R-HSA-176187","R-HSA-176187","Activation of ATR in response to replication stress","1/49","16/2914",0.238176638815721,0.382473434594589,0.268097407502906,"ATR",1
"R-HSA-196299","R-HSA-196299","Beta-catenin phosphorylation cascade","1/49","16/2914",0.238176638815721,0.382473434594589,0.268097407502906,"CTNNB1",1
"R-HSA-3232118","R-HSA-3232118","SUMOylation of transcription factors","1/49","16/2914",0.238176638815721,0.382473434594589,0.268097407502906,"TP53",1
"R-HSA-5637815","R-HSA-5637815","Signaling by Ligand-Responsive EGFR Variants in Cancer","1/49","16/2914",0.238176638815721,0.382473434594589,0.268097407502906,"SHC1",1
"R-HSA-9034015","R-HSA-9034015","Signaling by NTRK3 (TRKC)","1/49","16/2914",0.238176638815721,0.382473434594589,0.268097407502906,"SHC1",1
"R-HSA-174048","R-HSA-174048","APC/C:Cdc20 mediated degradation of Cyclin B","1/49","17/2914",0.251057710140093,0.399661760009234,0.280145683451449,"CDK1",1
"R-HSA-210993","R-HSA-210993","Tie2 Signaling","1/49","17/2914",0.251057710140093,0.399661760009234,0.280145683451449,"SHC1",1
"R-HSA-422475","R-HSA-422475","Axon guidance","6/49","254/2914",0.251605244369449,0.399661760009234,0.280145683451449,"MAPK1/RPS6KA2/SHC1/CSNK2A1/CSNK2B/RPS6KA5",6
"R-HSA-76002","R-HSA-76002","Platelet activation, signaling and aggregation","4/49","153/2914",0.254583683301673,0.40293820378682,0.282442329448656,"MAPK1/SHC1/YWHAZ/RAF1",4
"R-HSA-111885","R-HSA-111885","Opioid Signalling","2/49","59/2914",0.261197077203694,0.41192370598432,0.288740779553603,"MAPK1/PPP1CA",2
"R-HSA-5654704","R-HSA-5654704","SHC-mediated cascade:FGFR3","1/49","18/2914",0.263725356741107,0.412950736534117,0.289460683742814,"SHC1",1
"R-HSA-69273","R-HSA-69273","Cyclin A/B1/B2 associated events during G2/M transition","1/49","18/2914",0.263725356741107,0.412950736534117,0.289460683742814,"CDK1",1
"R-HSA-9612973","R-HSA-9612973","Autophagy","2/49","61/2914",0.273802668311,0.426387854854184,0.298879525053292,"CSNK2A1/CSNK2B",2
"R-HSA-2980766","R-HSA-2980766","Nuclear Envelope Breakdown","1/49","19/2914",0.276183042348733,0.426387854854184,0.298879525053292,"CDK1",1
"R-HSA-421270","R-HSA-421270","Cell-cell junction organization","1/49","19/2914",0.276183042348733,0.426387854854184,0.298879525053292,"CTNNB1",1
"R-HSA-5654719","R-HSA-5654719","SHC-mediated cascade:FGFR4","1/49","19/2914",0.276183042348733,0.426387854854184,0.298879525053292,"SHC1",1
"R-HSA-6806834","R-HSA-6806834","Signaling by MET","2/49","62/2914",0.280105584593498,0.430931668605382,0.302064542826261,"SHC1/STAT3",2
"R-HSA-9009391","R-HSA-9009391","Extra-nuclear estrogen signaling","2/49","63/2914",0.286406254647813,0.436120403053941,0.305701622236375,"MAPK1/SHC1",2
"R-HSA-167044","R-HSA-167044","Signalling to RAS","1/49","20/2914",0.288434175656129,0.436120403053941,0.305701622236375,"SHC1",1
"R-HSA-450321","R-HSA-450321","JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1","1/49","20/2914",0.288434175656129,0.436120403053941,0.305701622236375,"MAPK9",1
"R-HSA-6783310","R-HSA-6783310","Fanconi Anemia Pathway","1/49","20/2914",0.288434175656129,0.436120403053941,0.305701622236375,"ATR",1
"R-HSA-8936459","R-HSA-8936459","RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function","1/49","20/2914",0.288434175656129,0.436120403053941,0.305701622236375,"KMT2A",1
"R-HSA-1980143","R-HSA-1980143","Signaling by NOTCH1","2/49","64/2914",0.292703003759244,0.441059320733108,0.309163590848805,"MYC/NOTCH1",2
"R-HSA-111465","R-HSA-111465","Apoptotic cleavage of cellular proteins","1/49","21/2914",0.300482111175428,0.448176708193858,0.314152572968422,"CTNNB1",1
"R-HSA-3781865","R-HSA-3781865","Diseases of glycosylation","1/49","21/2914",0.300482111175428,0.448176708193858,0.314152572968422,"NOTCH1",1
"R-HSA-5654688","R-HSA-5654688","SHC-mediated cascade:FGFR1","1/49","21/2914",0.300482111175428,0.448176708193858,0.314152572968422,"SHC1",1
"R-HSA-1250196","R-HSA-1250196","SHC1 events in ERBB2 signaling","1/49","22/2914",0.31233015008051,0.455050549786174,0.318970839921887,"SHC1",1
"R-HSA-1266695","R-HSA-1266695","Interleukin-7 signaling","1/49","22/2914",0.31233015008051,0.455050549786174,0.318970839921887,"STAT3",1
"R-HSA-1500620","R-HSA-1500620","Meiosis","1/49","22/2914",0.31233015008051,0.455050549786174,0.318970839921887,"ATR",1
"R-HSA-1643713","R-HSA-1643713","Signaling by EGFR in Cancer","1/49","22/2914",0.31233015008051,0.455050549786174,0.318970839921887,"SHC1",1
"R-HSA-180024","R-HSA-180024","DARPP-32 events","1/49","22/2914",0.31233015008051,0.455050549786174,0.318970839921887,"PPP1CA",1
"R-HSA-69563","R-HSA-69563","p53-Dependent G1 DNA Damage Response","1/49","22/2914",0.31233015008051,0.455050549786174,0.318970839921887,"TP53",1
"R-HSA-69580","R-HSA-69580","p53-Dependent G1/S DNA damage checkpoint","1/49","22/2914",0.31233015008051,0.455050549786174,0.318970839921887,"TP53",1
"R-HSA-201451","R-HSA-201451","Signaling by BMP","1/49","23/2914",0.323981541036961,0.464139146937137,0.325341555149715,"SMAD4",1
"R-HSA-5654699","R-HSA-5654699","SHC-mediated cascade:FGFR2","1/49","23/2914",0.323981541036961,0.464139146937137,0.325341555149715,"SHC1",1
"R-HSA-5685938","R-HSA-5685938","HDR through Single Strand Annealing (SSA)","1/49","23/2914",0.323981541036961,0.464139146937137,0.325341555149715,"ATR",1
"R-HSA-5693616","R-HSA-5693616","Presynaptic phase of homologous DNA pairing and strand exchange","1/49","23/2914",0.323981541036961,0.464139146937137,0.325341555149715,"ATR",1
"R-HSA-69002","R-HSA-69002","DNA Replication Pre-Initiation","1/49","23/2914",0.323981541036961,0.464139146937137,0.325341555149715,"E2F1",1
"R-HSA-1474165","R-HSA-1474165","Reproduction","1/49","24/2914",0.335439481019385,0.464139146937137,0.325341555149715,"ATR",1
"R-HSA-186712","R-HSA-186712","Regulation of beta-cell development","1/49","24/2914",0.335439481019385,0.464139146937137,0.325341555149715,"NOTCH1",1
"R-HSA-2172127","R-HSA-2172127","DAP12 interactions","1/49","24/2914",0.335439481019385,0.464139146937137,0.325341555149715,"SHC1",1
"R-HSA-2424491","R-HSA-2424491","DAP12 signaling","1/49","24/2914",0.335439481019385,0.464139146937137,0.325341555149715,"SHC1",1
"R-HSA-5674400","R-HSA-5674400","Constitutive Signaling by AKT1 E17K in Cancer","1/49","24/2914",0.335439481019385,0.464139146937137,0.325341555149715,"FOXO4",1
"R-HSA-5693579","R-HSA-5693579","Homologous DNA Pairing and Strand Exchange","1/49","24/2914",0.335439481019385,0.464139146937137,0.325341555149715,"ATR",1
"R-HSA-69615","R-HSA-69615","G1/S DNA Damage Checkpoints","1/49","24/2914",0.335439481019385,0.464139146937137,0.325341555149715,"TP53",1
"R-HSA-9006335","R-HSA-9006335","Signaling by Erythropoietin","1/49","24/2914",0.335439481019385,0.464139146937137,0.325341555149715,"SHC1",1
"R-HSA-912694","R-HSA-912694","Regulation of IFNA signaling","1/49","24/2914",0.335439481019385,0.464139146937137,0.325341555149715,"STAT1",1
"R-HSA-9634638","R-HSA-9634638","Estrogen-dependent nuclear events downstream of ESR-membrane signaling","1/49","24/2914",0.335439481019385,0.464139146937137,0.325341555149715,"MAPK1",1
"R-HSA-194315","R-HSA-194315","Signaling by Rho GTPases","5/49","228/2914",0.336869444749648,0.464139146937137,0.325341555149715,"MAPK1/SFN/YWHAZ/CTNNB1/PIN1",5
"R-HSA-5621481","R-HSA-5621481","C-type lectin receptors (CLRs)","2/49","72/2914",0.34275232605003,0.464139146937137,0.325341555149715,"RAF1/RPS6KA5",2
"R-HSA-354192","R-HSA-354192","Integrin alphaIIb beta3 signaling","1/49","25/2914",0.346707116116288,0.464139146937137,0.325341555149715,"SHC1",1
"R-HSA-380259","R-HSA-380259","Loss of Nlp from mitotic centrosomes","1/49","25/2914",0.346707116116288,0.464139146937137,0.325341555149715,"CDK1",1
"R-HSA-380284","R-HSA-380284","Loss of proteins required for interphase microtubule organization from the centrosome","1/49","25/2914",0.346707116116288,0.464139146937137,0.325341555149715,"CDK1",1
"R-HSA-456926","R-HSA-456926","Thrombin signalling through proteinase activated receptors (PARs)","1/49","25/2914",0.346707116116288,0.464139146937137,0.325341555149715,"MAPK1",1
"R-HSA-5218920","R-HSA-5218920","VEGFR2 mediated vascular permeability","1/49","25/2914",0.346707116116288,0.464139146937137,0.325341555149715,"CTNNB1",1
"R-HSA-5654708","R-HSA-5654708","Downstream signaling of activated FGFR3","1/49","25/2914",0.346707116116288,0.464139146937137,0.325341555149715,"SHC1",1
"R-HSA-5663213","R-HSA-5663213","RHO GTPases Activate WASPs and WAVEs","1/49","25/2914",0.346707116116288,0.464139146937137,0.325341555149715,"MAPK1",1
"R-HSA-9006115","R-HSA-9006115","Signaling by NTRK2 (TRKB)","1/49","25/2914",0.346707116116288,0.464139146937137,0.325341555149715,"SHC1",1
"R-HSA-9006921","R-HSA-9006921","Integrin signaling","1/49","25/2914",0.346707116116288,0.464139146937137,0.325341555149715,"SHC1",1
"R-HSA-5684996","R-HSA-5684996","MAPK1/MAPK3 signaling","4/49","177/2914",0.347049498505268,0.464139146937137,0.325341555149715,"MAPK1/SHC1/CDK1/RAF1",4
"R-HSA-111996","R-HSA-111996","Ca-dependent events","1/49","26/2914",0.357787542322692,0.467141004813011,0.327445728254096,"MAPK1",1
"R-HSA-350054","R-HSA-350054","Notch-HLH transcription pathway","1/49","26/2914",0.357787542322692,0.467141004813011,0.327445728254096,"NOTCH1",1
"R-HSA-380320","R-HSA-380320","Recruitment of NuMA to mitotic centrosomes","1/49","26/2914",0.357787542322692,0.467141004813011,0.327445728254096,"CDK1",1
"R-HSA-5654716","R-HSA-5654716","Downstream signaling of activated FGFR4","1/49","26/2914",0.357787542322692,0.467141004813011,0.327445728254096,"SHC1",1
"R-HSA-75153","R-HSA-75153","Apoptotic execution phase","1/49","26/2914",0.357787542322692,0.467141004813011,0.327445728254096,"CTNNB1",1
"R-HSA-8854518","R-HSA-8854518","AURKA Activation by TPX2","1/49","26/2914",0.357787542322692,0.467141004813011,0.327445728254096,"CDK1",1
"R-HSA-912526","R-HSA-912526","Interleukin receptor SHC signaling","1/49","26/2914",0.357787542322692,0.467141004813011,0.327445728254096,"SHC1",1
"R-HSA-936440","R-HSA-936440","Negative regulators of DDX58/IFIH1 signaling","1/49","26/2914",0.357787542322692,0.467141004813011,0.327445728254096,"PIN1",1
"R-HSA-1251985","R-HSA-1251985","Nuclear signaling by ERBB4","1/49","27/2914",0.36868380632068,0.470205434148114,0.329593761256932,"YAP1",1
"R-HSA-174184","R-HSA-174184","Cdc20:Phospho-APC/C mediated degradation of Cyclin A","1/49","27/2914",0.36868380632068,0.470205434148114,0.329593761256932,"CDK1",1
"R-HSA-2122948","R-HSA-2122948","Activated NOTCH1 Transmits Signal to the Nucleus","1/49","27/2914",0.36868380632068,0.470205434148114,0.329593761256932,"NOTCH1",1
"R-HSA-380270","R-HSA-380270","Recruitment of mitotic centrosome proteins and complexes","1/49","27/2914",0.36868380632068,0.470205434148114,0.329593761256932,"CDK1",1
"R-HSA-380287","R-HSA-380287","Centrosome maturation","1/49","27/2914",0.36868380632068,0.470205434148114,0.329593761256932,"CDK1",1
"R-HSA-5617472","R-HSA-5617472","Activation of anterior HOX genes in hindbrain development during early embryogenesis","1/49","27/2914",0.36868380632068,0.470205434148114,0.329593761256932,"JUN",1
"R-HSA-5619507","R-HSA-5619507","Activation of HOX genes during differentiation","1/49","27/2914",0.36868380632068,0.470205434148114,0.329593761256932,"JUN",1
"R-HSA-5654732","R-HSA-5654732","Negative regulation of FGFR3 signaling","1/49","27/2914",0.36868380632068,0.470205434148114,0.329593761256932,"MAPK1",1
"R-HSA-112314","R-HSA-112314","Neurotransmitter receptors and postsynaptic signal transmission","2/49","77/2914",0.373535951870406,0.474248632810049,0.332427869409915,"MAPK1/RPS6KA2",2
"R-HSA-179419","R-HSA-179419","APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint","1/49","28/2914",0.379398906248039,0.474248632810049,0.332427869409915,"CDK1",1
"R-HSA-4090294","R-HSA-4090294","SUMOylation of intracellular receptors","1/49","28/2914",0.379398906248039,0.474248632810049,0.332427869409915,"VDR",1
"R-HSA-5620912","R-HSA-5620912","Anchoring of the basal body to the plasma membrane","1/49","28/2914",0.379398906248039,0.474248632810049,0.332427869409915,"CDK1",1
"R-HSA-5654687","R-HSA-5654687","Downstream signaling of activated FGFR1","1/49","28/2914",0.379398906248039,0.474248632810049,0.332427869409915,"SHC1",1
"R-HSA-5654733","R-HSA-5654733","Negative regulation of FGFR4 signaling","1/49","28/2914",0.379398906248039,0.474248632810049,0.332427869409915,"MAPK1",1
"R-HSA-8957322","R-HSA-8957322","Metabolism of steroids","1/49","28/2914",0.379398906248039,0.474248632810049,0.332427869409915,"VDR",1
"R-HSA-176409","R-HSA-176409","APC/C:Cdc20 mediated degradation of mitotic proteins","1/49","29/2914",0.389935792455193,0.483300700507845,0.338772979064112,"CDK1",1
"R-HSA-2871809","R-HSA-2871809","FCERI mediated Ca+2 mobilization","1/49","29/2914",0.389935792455193,0.483300700507845,0.338772979064112,"SHC1",1
"R-HSA-5673000","R-HSA-5673000","RAF activation","1/49","29/2914",0.389935792455193,0.483300700507845,0.338772979064112,"RAF1",1
"R-HSA-5693532","R-HSA-5693532","DNA Double-Strand Break Repair","2/49","81/2914",0.39777070752407,0.489252338972933,0.342944821337487,"TP53/ATR",2
"R-HSA-176814","R-HSA-176814","Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins","1/49","30/2914",0.400297368250582,0.489252338972933,0.342944821337487,"CDK1",1
"R-HSA-4641262","R-HSA-4641262","Disassembly of the destruction complex and recruitment of AXIN to the membrane","1/49","30/2914",0.400297368250582,0.489252338972933,0.342944821337487,"CTNNB1",1
"R-HSA-5654696","R-HSA-5654696","Downstream signaling of activated FGFR2","1/49","30/2914",0.400297368250582,0.489252338972933,0.342944821337487,"SHC1",1
"R-HSA-5654726","R-HSA-5654726","Negative regulation of FGFR1 signaling","1/49","30/2914",0.400297368250582,0.489252338972933,0.342944821337487,"MAPK1",1
"R-HSA-446652","R-HSA-446652","Interleukin-1 family signaling","2/49","82/2914",0.403766914029727,0.49212587859579,0.344959048872168,"SMAD3/STAT3",2
"R-HSA-3214841","R-HSA-3214841","PKMTs methylate histone lysines","1/49","31/2914",0.410486490634674,0.496192461206749,0.347809548166453,"KMT2A",1
"R-HSA-450531","R-HSA-450531","Regulation of mRNA stability by proteins that bind AU-rich elements","1/49","31/2914",0.410486490634674,0.496192461206749,0.347809548166453,"YWHAZ",1
"R-HSA-4791275","R-HSA-4791275","Signaling by WNT in cancer","1/49","31/2914",0.410486490634674,0.496192461206749,0.347809548166453,"CTNNB1",1
"R-HSA-5654727","R-HSA-5654727","Negative regulation of FGFR2 signaling","1/49","32/2914",0.420505971022777,0.505526303961808,0.354352170001938,"MAPK1",1
"R-HSA-8853659","R-HSA-8853659","RET signaling","1/49","32/2914",0.420505971022777,0.505526303961808,0.354352170001938,"SHC1",1
"R-HSA-5685942","R-HSA-5685942","HDR through Homologous Recombination (HRR)","1/49","33/2914",0.43035857595681,0.513582738023161,0.359999383351163,"ATR",1
"R-HSA-76009","R-HSA-76009","Platelet Aggregation (Plug Formation)","1/49","33/2914",0.43035857595681,0.513582738023161,0.359999383351163,"SHC1",1
"R-HSA-112315","R-HSA-112315","Transmission across Chemical Synapses","2/49","88/2914",0.439156282677815,0.513582738023161,0.359999383351163,"MAPK1/RPS6KA2",2
"R-HSA-112040","R-HSA-112040","G-protein mediated events","1/49","34/2914",0.440047027806208,0.513582738023161,0.359999383351163,"MAPK1",1
"R-HSA-112043","R-HSA-112043","PLC beta mediated events","1/49","34/2914",0.440047027806208,0.513582738023161,0.359999383351163,"MAPK1",1
"R-HSA-176408","R-HSA-176408","Regulation of APC/C activators between G1/S and early anaphase","1/49","34/2914",0.440047027806208,0.513582738023161,0.359999383351163,"CDK1",1
"R-HSA-1834949","R-HSA-1834949","Cytosolic sensors of pathogen-associated DNA ","1/49","34/2914",0.440047027806208,0.513582738023161,0.359999383351163,"CTNNB1",1
"R-HSA-2500257","R-HSA-2500257","Resolution of Sister Chromatid Cohesion","1/49","34/2914",0.440047027806208,0.513582738023161,0.359999383351163,"CDK1",1
"R-HSA-2672351","R-HSA-2672351","Stimuli-sensing channels","1/49","34/2914",0.440047027806208,0.513582738023161,0.359999383351163,"RAF1",1
"R-HSA-3214847","R-HSA-3214847","HATs acetylate histones","1/49","34/2914",0.440047027806208,0.513582738023161,0.359999383351163,"ATF2",1
"R-HSA-5693565","R-HSA-5693565","Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks","1/49","34/2914",0.440047027806208,0.513582738023161,0.359999383351163,"TP53",1
"R-HSA-446728","R-HSA-446728","Cell junction organization","1/49","35/2914",0.449574005458117,0.520559374740977,0.36488970526102,"CTNNB1",1
"R-HSA-5576891","R-HSA-5576891","Cardiac conduction","1/49","35/2914",0.449574005458117,0.520559374740977,0.36488970526102,"WWTR1",1
"R-HSA-5693606","R-HSA-5693606","DNA Double Strand Break Response","1/49","35/2914",0.449574005458117,0.520559374740977,0.36488970526102,"TP53",1
"R-HSA-195253","R-HSA-195253","Degradation of beta-catenin by the destruction complex","1/49","37/2914",0.468154040374086,0.539235020326172,0.377980528601838,"CTNNB1",1
"R-HSA-2565942","R-HSA-2565942","Regulation of PLK1 Activity at G2/M Transition","1/49","37/2914",0.468154040374086,0.539235020326172,0.377980528601838,"CDK1",1
"R-HSA-983712","R-HSA-983712","Ion channel transport","1/49","39/2914",0.486119267724135,0.558465999474202,0.391460616856319,"RAF1",1
"R-HSA-913531","R-HSA-913531","Interferon Signaling","2/49","97/2914",0.490113020605054,0.561587836109958,0.393648889904827,"PIN1/STAT1",2
"R-HSA-174143","R-HSA-174143","APC/C-mediated degradation of cell cycle proteins","1/49","40/2914",0.494877582813359,0.562651515343354,0.394394483243069,"CDK1",1
"R-HSA-4086398","R-HSA-4086398","Ca2+ pathway","1/49","40/2914",0.494877582813359,0.562651515343354,0.394394483243069,"CTNNB1",1
"R-HSA-453276","R-HSA-453276","Regulation of mitotic cell cycle","1/49","40/2914",0.494877582813359,0.562651515343354,0.394394483243069,"CDK1",1
"R-HSA-597592","R-HSA-597592","Post-translational protein modification","7/49","393/2914",0.498017191295922,0.564761763325272,0.395873676206471,"MYC/SMAD3/SMAD4/TP53/CDK1/FOXO4/VDR",7
"R-HSA-8986944","R-HSA-8986944","Transcriptional Regulation by MECP2","1/49","41/2914",0.503489621241384,0.569499828653494,0.399194855970033,"MEF2C",1
"R-HSA-2980736","R-HSA-2980736","Peptide hormone metabolism","1/49","42/2914",0.511957775978305,0.573184278448993,0.40177749661616,"CTNNB1",1
"R-HSA-5617833","R-HSA-5617833","Cilium Assembly","1/49","42/2914",0.511957775978305,0.573184278448993,0.40177749661616,"CDK1",1
"R-HSA-6783783","R-HSA-6783783","Interleukin-10 signaling","1/49","42/2914",0.511957775978305,0.573184278448993,0.40177749661616,"STAT3",1
"R-HSA-909733","R-HSA-909733","Interferon alpha/beta signaling","1/49","42/2914",0.511957775978305,0.573184278448993,0.40177749661616,"STAT1",1
"R-HSA-2029482","R-HSA-2029482","Regulation of actin dynamics for phagocytic cup formation","1/49","43/2914",0.520284401666697,0.581028265820677,0.40727579398435,"MAPK1",1
"R-HSA-1227986","R-HSA-1227986","Signaling by ERBB2","1/49","44/2914",0.528471815222368,0.587190905802631,0.411595539234859,"SHC1",1
"R-HSA-177929","R-HSA-177929","Signaling by EGFR","1/49","44/2914",0.528471815222368,0.587190905802631,0.411595539234859,"SHC1",1
"R-HSA-112316","R-HSA-112316","Neuronal System","2/49","105/2914",0.533005991157326,0.590737118663032,0.414081281742269,"MAPK1/RPS6KA2",2
"R-HSA-3108232","R-HSA-3108232","SUMO E3 ligases SUMOylate target proteins","2/49","107/2914",0.543353963992396,0.600382854491791,0.420842527191615,"TP53/VDR",2
"R-HSA-383280","R-HSA-383280","Nuclear Receptor transcription pathway","1/49","46/2914",0.544438088505056,0.600382854491791,0.420842527191615,"VDR",1
"R-HSA-877300","R-HSA-877300","Interferon gamma signaling","1/49","47/2914",0.552221398708422,0.601385450686223,0.421545303949912,"STAT1",1
"R-HSA-8848021","R-HSA-8848021","Signaling by PTK6","1/49","47/2914",0.552221398708422,0.601385450686223,0.421545303949912,"STAT3",1
"R-HSA-9006927","R-HSA-9006927","Signaling by Non-Receptor Tyrosine Kinases","1/49","47/2914",0.552221398708422,0.601385450686223,0.421545303949912,"STAT3",1
"R-HSA-2990846","R-HSA-2990846","SUMOylation","2/49","109/2914",0.553547971654364,0.601385450686223,0.421545303949912,"TP53/VDR",2
"R-HSA-3247509","R-HSA-3247509","Chromatin modifying enzymes","2/49","109/2914",0.553547971654364,0.601385450686223,0.421545303949912,"ATF2/KMT2A",2
"R-HSA-4839726","R-HSA-4839726","Chromatin organization","2/49","109/2914",0.553547971654364,0.601385450686223,0.421545303949912,"ATF2/KMT2A",2
"R-HSA-5673001","R-HSA-5673001","RAF/MAP kinase cascade","3/49","171/2914",0.556177970794949,0.602754451107827,0.422504914293285,"MAPK1/SHC1/RAF1",3
"R-HSA-5693607","R-HSA-5693607","Processing of DNA double-strand break ends","1/49","48/2914",0.559874398870015,0.605269620400016,0.424267939658385,"ATR",1
"R-HSA-109582","R-HSA-109582","Hemostasis","5/49","298/2914",0.572458786400216,0.617357514745331,0.432741033063115,"MAPK1/SHC1/TP53/YWHAZ/RAF1",5
"R-HSA-2404192","R-HSA-2404192","Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)","1/49","51/2914",0.582072737844135,0.623143563628758,0.436796804170397,"SHC1",1
"R-HSA-2428924","R-HSA-2428924","IGF1R signaling cascade","1/49","51/2914",0.582072737844135,0.623143563628758,0.436796804170397,"SHC1",1
"R-HSA-69306","R-HSA-69306","DNA Replication","1/49","51/2914",0.582072737844135,0.623143563628758,0.436796804170397,"E2F1",1
"R-HSA-397014","R-HSA-397014","Muscle contraction","1/49","53/2914",0.596258353576099,0.636780765955058,0.446355895753186,"WWTR1",1
"R-HSA-9607240","R-HSA-9607240","FLT3 Signaling","3/49","188/2914",0.622202125135329,0.66236895583104,0.464292114972475,"MAPK1/SHC1/RAF1",3
"R-HSA-1500931","R-HSA-1500931","Cell-Cell communication","1/49","57/2914",0.623228972077387,0.66236895583104,0.464292114972475,"CTNNB1",1
"R-HSA-6798695","R-HSA-6798695","Neutrophil degranulation","2/49","125/2914",0.629436633034646,0.667354502494564,0.467786768494994,"MAPK1/CSNK2B",2
"R-HSA-5693567","R-HSA-5693567","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","1/49","59/2914",0.6360442603915,0.672739121567933,0.471561154591877,"ATR",1
"R-HSA-2029480","R-HSA-2029480","Fcgamma receptor (FCGR) dependent phagocytosis","1/49","62/2914",0.654470396987362,0.688916207355118,0.482900595107774,"MAPK1",1
"R-HSA-983231","R-HSA-983231","Factors involved in megakaryocyte development and platelet production","1/49","62/2914",0.654470396987362,0.688916207355118,0.482900595107774,"TP53",1
"R-HSA-5693538","R-HSA-5693538","Homology Directed Repair","1/49","63/2914",0.660406915412193,0.693506068690609,0.486117890254422,"ATR",1
"R-HSA-168928","R-HSA-168928","DDX58/IFIH1-mediated induction of interferon-alpha/beta","1/49","66/2914",0.677623346769445,0.709891125187038,0.497603109281823,"PIN1",1
"R-HSA-202733","R-HSA-202733","Cell surface interactions at the vascular wall","1/49","69/2914",0.693983876434274,0.725303813850548,0.508406740330647,"SHC1",1
"R-HSA-199991","R-HSA-199991","Membrane Trafficking","2/49","144/2914",0.706460665863619,0.736594059194295,0.5163207161338,"SFN/YWHAZ",2
"R-HSA-3858494","R-HSA-3858494","Beta-catenin independent WNT signaling","1/49","76/2914",0.729060504633985,0.758360808602727,0.531578270144974,"CTNNB1",1
"R-HSA-1430728","R-HSA-1430728","Metabolism","4/49","289/2914",0.731381493040503,0.758980794664673,0.532012853676434,"CSNK2A1/CSNK2B/PPP1CA/VDR",4
"R-HSA-73894","R-HSA-73894","DNA Repair","2/49","157/2914",0.751328859286039,0.777846348437311,0.545236794478785,"TP53/ATR",2
"R-HSA-5653656","R-HSA-5653656","Vesicle-mediated transport","2/49","160/2914",0.760831135070643,0.785834975190335,0.550836477824804,"SFN/YWHAZ",2
"R-HSA-4420097","R-HSA-4420097","VEGFA-VEGFR2 Pathway","1/49","85/2914",0.768420323786076,0.791814853550055,0.555028115048245,"CTNNB1",1
"R-HSA-416476","R-HSA-416476","G alpha (q) signalling events","2/49","165/2914",0.775989399818644,0.797746111963092,0.559185671782742,"MAPK1/RPS6KA2",2
"R-HSA-194138","R-HSA-194138","Signaling by VEGF","1/49","92/2914",0.795107306848666,0.813598174449798,0.570297284961222,"CTNNB1",1
"R-HSA-6811558","R-HSA-6811558","PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling","1/49","92/2914",0.795107306848666,0.813598174449798,0.570297284961222,"MAPK1",1
"R-HSA-2219528","R-HSA-2219528","PI3K/AKT Signaling in Cancer","1/49","97/2914",0.812300312956048,0.829262500465571,0.581277302957924,"FOXO4",1
"R-HSA-199418","R-HSA-199418","Negative regulation of the PI3K/AKT network","1/49","99/2914",0.818774504447921,0.833936995271031,0.584553922522517,"MAPK1",1
"R-HSA-8953854","R-HSA-8953854","Metabolism of RNA","1/49","109/2914",0.848003427741551,0.861712490083793,0.604023348312324,"YWHAZ",1
"R-HSA-382551","R-HSA-382551","Transport of small molecules","1/49","121/2914",0.877027562606926,0.889152367619925,0.623257520843631,"RAF1",1
"R-HSA-5663205","R-HSA-5663205","Infectious disease","1/49","126/2914",0.887449911484194,0.897650485179415,0.629214335305188,"CTNNB1",1
"R-HSA-418594","R-HSA-418594","G alpha (i) signalling events","2/49","217/2914",0.890580896708939,0.898751363651223,0.629986003707675,"MAPK1/PPP1CA",2
"R-HSA-1280218","R-HSA-1280218","Adaptive Immune System","2/49","296/2914",0.966666953702863,0.973303111279771,0.682243568432949,"YWHAZ/RAF1",2
"R-HSA-388396","R-HSA-388396","GPCR downstream signalling","3/49","436/2914",0.984263966121316,0.988758322131002,0.693077005704267,"MAPK1/RPS6KA2/PPP1CA",3
"R-HSA-372790","R-HSA-372790","Signaling by GPCR","3/49","486/2914",0.992767893410473,0.995029323691591,0.69747270775511,"MAPK1/RPS6KA2/PPP1CA",3
"R-HSA-5689603","R-HSA-5689603","UCH proteinases","0/49","27/2914",1,1,0.700956937799043,"",0
